Tranexamic acid reduces bleeding after off-pump coronary artery bypass grafting

Journal of Cardiovascular Surgery

Volumn 44, Issue 2, 2003, Pages 205-208

  Jares, Martin ^a   Vanek, T ^a   Straka, Z ^a   Brucek, P ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Coronary artery bypass; Hemorrage; Postoperative complications; Tranexamic acid

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; TRANEXAMIC ACID;

ARTICLE; BLOOD PUMP; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; ERYTHROCYTE TRANSFUSION; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMATOLOGICAL PARAMETERS; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LUNG EMBOLISM; MALE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PREOPERATIVE EVALUATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; STROKE;

ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 0038264388     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Wong BI, McLean RF, Fremes SE, Deemar KA, Harrington EM, Christakis GT et al. Aprotinin and tranexamic acid for high transfusion risk cardiac surgery. Ann Thorac Surg 2000;69:808-16.
2. Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJ, Briet E et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 1999;354:1940-7.
3. Casati V, Guzzon D, Oppizzi M, Bellotti F, Franco A, Gerli C et al. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogenic transfusions. J Thorac Cardiovasc Surg 2000;120:520-7
4. Casati V, Guzzon D, Oppizzi M, Cossolini M, Torri G, Calori G et al. Hemostatic effects of aprotinin, tranexamic acid and epsilon-aminocaproic acid in primary cardiac surgery. Ann Thorac Surg 1999;68:2252-6.
5. Coffey A, Pittmam J, Halbrook H, Fehrenbacher J, Beckman D, Hormuth D. The use of tranexamic acid to reduce postoperative bleeding following cardiac surgery: a double-blind randomized trial. Am Surg 1995;61:566-8.
6. Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Perioperative Transfusion (ISPOT) Investigators. Anesth Analg 1997;85:1258-67.
7. Barrons RW, Jahr JS. A review of post-cardiopulmonary bypass bleeding, aminocaproic acid, tranexamic acid, and aprotinin. Am J Ther 1996;3:821-38.
8. Bernet F, Carrel T, Marbet G, Skarvan K, Stulz P. Reduction of blood loss and transfusion requirements after coronary artery bypass grafting: similar efficacy of tranexamic acid and aprotinin in aspirin-treated patients. J Card Surg 1999;14:92-7.
9. Landymore RW, Murphy JT, Lummis H, Carter C. The use of low-dose aprotinin, epsilon-aminocaproic acid or tranexamic acid for prevention of mediastinal bleeding in patients receiving aspirin before coronary artery bypass operations. Eur J Cardiothorac Surg 1997;11:798-800.
10. Casati V, Gerli C, Franco A, Torri G, D'Angelo A, Bennusi S et al. Tranexamic acid in off-pump coronary surgery: a preliminary, randomized, double-blind, placebo-controlled study. Ann Thorac Surg 2001;72:470-5.
11. Robblee JA. Graft occlusion following administration of tranexamic acid. Anesth Analg 1995;80 Suppl:SCA141.
12. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999;57:1005-32.
13. Ruel MA, Wang F, Bourke ME, Dupuis JY, Robblee JA, Keon WJ et al. Is tranexamic acid safe in patients undergoing coronary endarterectomy? Ann Thorac Surg 2001;71:1508-11.
14. Horrow JC, Van Riper DF, Strong MD, Brodsky I, Parmet JL. Hemostatic effect of tranexamic acid and desmopressin during cardiac surgery. Circulation 1991;84:2063-70.
15. Mariani MA, Gu YJ, Boonstra PW, Grandjean JG, van Oeveren W, Ebels T. Procoagulant activity after off-pump coronary operation: is the current anticoagulation adequate? Ann Thorac Surg 1999;67:1370-5.
16. Nader D, Khadra Z, Reich T, Bacon R, Salerno A, Panos L. Blood product use in cardiac revascularization: comparison of on- and off-pump techniques. Ann Thorac Surg 1999;68:1640-3.